SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016486
Filing Date
2022-08-10
Accepted
2022-08-10 16:22:17
Documents
66
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sprb-20220630.htm   iXBRL 10-Q 3052150
2 EX-31.1 sprb-ex31_1.htm EX-31.1 21086
3 EX-31.2 sprb-ex31_2.htm EX-31.2 19422
4 EX-32.1 sprb-ex32_1.htm EX-32.1 10405
5 EX-32.2 sprb-ex32_2.htm EX-32.2 10569
  Complete submission text file 0000950170-22-016486.txt   9449435

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sprb-20220630_lab.xml EX-101.LAB 430989
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sprb-20220630.xsd EX-101.SCH 50209
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sprb-20220630_def.xml EX-101.DEF 170616
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sprb-20220630_cal.xml EX-101.CAL 41368
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sprb-20220630_pre.xml EX-101.PRE 302954
60 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20220630_htm.xml XML 1769083
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39594 | Film No.: 221152122
SIC: 2834 Pharmaceutical Preparations